nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Ifosfamide—testicular cancer	0.0852	0.441	CbGbCtD
Flecainide—CYP2C9—Cisplatin—testicular cancer	0.0415	0.214	CbGbCtD
Flecainide—CYP2D6—Vinblastine—testicular cancer	0.0414	0.214	CbGbCtD
Flecainide—CYP2D6—Doxorubicin—testicular cancer	0.0254	0.131	CbGbCtD
Flecainide—Pneumonia—Methotrexate—testicular cancer	0.000924	0.00115	CcSEcCtD
Flecainide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000922	0.00114	CcSEcCtD
Flecainide—Vomiting—Bleomycin—testicular cancer	0.000922	0.00114	CcSEcCtD
Flecainide—Hypotension—Etoposide—testicular cancer	0.000914	0.00113	CcSEcCtD
Flecainide—Rash—Bleomycin—testicular cancer	0.000914	0.00113	CcSEcCtD
Flecainide—Pain—Cisplatin—testicular cancer	0.000913	0.00113	CcSEcCtD
Flecainide—Dermatitis—Bleomycin—testicular cancer	0.000913	0.00113	CcSEcCtD
Flecainide—Renal failure—Methotrexate—testicular cancer	0.000903	0.00112	CcSEcCtD
Flecainide—Dysuria—Epirubicin—testicular cancer	0.000902	0.00112	CcSEcCtD
Flecainide—Asthenia—Ifosfamide—testicular cancer	0.000889	0.0011	CcSEcCtD
Flecainide—Photosensitivity reaction—Epirubicin—testicular cancer	0.00088	0.00109	CcSEcCtD
Flecainide—Feeling abnormal—Cisplatin—testicular cancer	0.00088	0.00109	CcSEcCtD
Flecainide—Paraesthesia—Etoposide—testicular cancer	0.000878	0.00109	CcSEcCtD
Flecainide—Pruritus—Ifosfamide—testicular cancer	0.000876	0.00109	CcSEcCtD
Flecainide—Haematuria—Methotrexate—testicular cancer	0.000876	0.00109	CcSEcCtD
Flecainide—Dyspnoea—Etoposide—testicular cancer	0.000872	0.00108	CcSEcCtD
Flecainide—Hyperglycaemia—Epirubicin—testicular cancer	0.00087	0.00108	CcSEcCtD
Flecainide—Somnolence—Etoposide—testicular cancer	0.00087	0.00108	CcSEcCtD
Flecainide—Angina pectoris—Doxorubicin—testicular cancer	0.000869	0.00108	CcSEcCtD
Flecainide—Pneumonia—Epirubicin—testicular cancer	0.000865	0.00107	CcSEcCtD
Flecainide—Nausea—Bleomycin—testicular cancer	0.000861	0.00107	CcSEcCtD
Flecainide—Vomiting—Dactinomycin—testicular cancer	0.000859	0.00107	CcSEcCtD
Flecainide—Agranulocytosis—Methotrexate—testicular cancer	0.000857	0.00106	CcSEcCtD
Flecainide—Rash—Dactinomycin—testicular cancer	0.000852	0.00106	CcSEcCtD
Flecainide—Decreased appetite—Etoposide—testicular cancer	0.00085	0.00105	CcSEcCtD
Flecainide—Diarrhoea—Ifosfamide—testicular cancer	0.000848	0.00105	CcSEcCtD
Flecainide—Renal failure—Epirubicin—testicular cancer	0.000845	0.00105	CcSEcCtD
Flecainide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000845	0.00105	CcSEcCtD
Flecainide—Body temperature increased—Cisplatin—testicular cancer	0.000844	0.00105	CcSEcCtD
Flecainide—Fatigue—Etoposide—testicular cancer	0.000843	0.00105	CcSEcCtD
Flecainide—Neuropathy peripheral—Epirubicin—testicular cancer	0.000843	0.00105	CcSEcCtD
Flecainide—Jaundice—Epirubicin—testicular cancer	0.000838	0.00104	CcSEcCtD
Flecainide—Constipation—Etoposide—testicular cancer	0.000837	0.00104	CcSEcCtD
Flecainide—Pain—Etoposide—testicular cancer	0.000837	0.00104	CcSEcCtD
Flecainide—Dysuria—Doxorubicin—testicular cancer	0.000834	0.00103	CcSEcCtD
Flecainide—Haematuria—Epirubicin—testicular cancer	0.00082	0.00102	CcSEcCtD
Flecainide—Dizziness—Ifosfamide—testicular cancer	0.000819	0.00102	CcSEcCtD
Flecainide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000814	0.00101	CcSEcCtD
Flecainide—Feeling abnormal—Etoposide—testicular cancer	0.000806	0.001	CcSEcCtD
Flecainide—Hyperglycaemia—Doxorubicin—testicular cancer	0.000805	0.000998	CcSEcCtD
Flecainide—Nausea—Dactinomycin—testicular cancer	0.000803	0.000996	CcSEcCtD
Flecainide—Agranulocytosis—Epirubicin—testicular cancer	0.000802	0.000995	CcSEcCtD
Flecainide—Pneumonia—Doxorubicin—testicular cancer	0.0008	0.000992	CcSEcCtD
Flecainide—Gastrointestinal pain—Etoposide—testicular cancer	0.0008	0.000992	CcSEcCtD
Flecainide—Visual impairment—Methotrexate—testicular cancer	0.000795	0.000986	CcSEcCtD
Flecainide—Vomiting—Ifosfamide—testicular cancer	0.000788	0.000977	CcSEcCtD
Flecainide—Bradycardia—Epirubicin—testicular cancer	0.000786	0.000974	CcSEcCtD
Flecainide—Renal failure—Doxorubicin—testicular cancer	0.000782	0.00097	CcSEcCtD
Flecainide—Rash—Ifosfamide—testicular cancer	0.000781	0.000968	CcSEcCtD
Flecainide—Dermatitis—Ifosfamide—testicular cancer	0.00078	0.000967	CcSEcCtD
Flecainide—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00078	0.000967	CcSEcCtD
Flecainide—Urticaria—Etoposide—testicular cancer	0.000777	0.000964	CcSEcCtD
Flecainide—Jaundice—Doxorubicin—testicular cancer	0.000775	0.000962	CcSEcCtD
Flecainide—Abdominal pain—Etoposide—testicular cancer	0.000773	0.000959	CcSEcCtD
Flecainide—Body temperature increased—Etoposide—testicular cancer	0.000773	0.000959	CcSEcCtD
Flecainide—Eye disorder—Methotrexate—testicular cancer	0.000771	0.000956	CcSEcCtD
Flecainide—Tinnitus—Methotrexate—testicular cancer	0.000769	0.000954	CcSEcCtD
Flecainide—Hypoaesthesia—Epirubicin—testicular cancer	0.000768	0.000952	CcSEcCtD
Flecainide—Asthenia—Cisplatin—testicular cancer	0.000766	0.00095	CcSEcCtD
Flecainide—Haematuria—Doxorubicin—testicular cancer	0.000759	0.000941	CcSEcCtD
Flecainide—Immune system disorder—Methotrexate—testicular cancer	0.000745	0.000924	CcSEcCtD
Flecainide—Visual impairment—Epirubicin—testicular cancer	0.000744	0.000922	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—testicular cancer	0.000742	0.000921	CcSEcCtD
Flecainide—Nausea—Ifosfamide—testicular cancer	0.000736	0.000912	CcSEcCtD
Flecainide—Diarrhoea—Cisplatin—testicular cancer	0.000731	0.000906	CcSEcCtD
Flecainide—Alopecia—Methotrexate—testicular cancer	0.000729	0.000904	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—testicular cancer	0.000727	0.000902	CcSEcCtD
Flecainide—Eye disorder—Epirubicin—testicular cancer	0.000721	0.000894	CcSEcCtD
Flecainide—Tinnitus—Epirubicin—testicular cancer	0.00072	0.000892	CcSEcCtD
Flecainide—Flushing—Epirubicin—testicular cancer	0.000716	0.000888	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—testicular cancer	0.000711	0.000881	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—testicular cancer	0.000703	0.000872	CcSEcCtD
Flecainide—Asthenia—Etoposide—testicular cancer	0.000702	0.00087	CcSEcCtD
Flecainide—Immune system disorder—Epirubicin—testicular cancer	0.000697	0.000864	CcSEcCtD
Flecainide—Pruritus—Etoposide—testicular cancer	0.000692	0.000858	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—testicular cancer	0.000688	0.000853	CcSEcCtD
Flecainide—Alopecia—Epirubicin—testicular cancer	0.000682	0.000846	CcSEcCtD
Flecainide—Vomiting—Cisplatin—testicular cancer	0.000679	0.000842	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—testicular cancer	0.000677	0.000839	CcSEcCtD
Flecainide—Rash—Cisplatin—testicular cancer	0.000673	0.000835	CcSEcCtD
Flecainide—Dermatitis—Cisplatin—testicular cancer	0.000673	0.000834	CcSEcCtD
Flecainide—Diarrhoea—Etoposide—testicular cancer	0.000669	0.00083	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—testicular cancer	0.000667	0.000828	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—testicular cancer	0.000666	0.000826	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—testicular cancer	0.000666	0.000826	CcSEcCtD
Flecainide—Flushing—Doxorubicin—testicular cancer	0.000663	0.000822	CcSEcCtD
Flecainide—Flatulence—Epirubicin—testicular cancer	0.000662	0.000821	CcSEcCtD
Flecainide—Tension—Epirubicin—testicular cancer	0.000659	0.000818	CcSEcCtD
Flecainide—Dysgeusia—Epirubicin—testicular cancer	0.000658	0.000816	CcSEcCtD
Flecainide—Nervousness—Epirubicin—testicular cancer	0.000653	0.000809	CcSEcCtD
Flecainide—Malaise—Methotrexate—testicular cancer	0.000647	0.000803	CcSEcCtD
Flecainide—Dizziness—Etoposide—testicular cancer	0.000647	0.000802	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—testicular cancer	0.000645	0.0008	CcSEcCtD
Flecainide—Vertigo—Methotrexate—testicular cancer	0.000645	0.0008	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—testicular cancer	0.000643	0.000797	CcSEcCtD
Flecainide—Nausea—Cisplatin—testicular cancer	0.000634	0.000786	CcSEcCtD
Flecainide—Vision blurred—Epirubicin—testicular cancer	0.000633	0.000785	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—testicular cancer	0.000631	0.000783	CcSEcCtD
Flecainide—Cough—Methotrexate—testicular cancer	0.000627	0.000777	CcSEcCtD
Flecainide—Ill-defined disorder—Epirubicin—testicular cancer	0.000623	0.000773	CcSEcCtD
Flecainide—Convulsion—Methotrexate—testicular cancer	0.000622	0.000771	CcSEcCtD
Flecainide—Vomiting—Etoposide—testicular cancer	0.000622	0.000771	CcSEcCtD
Flecainide—Rash—Etoposide—testicular cancer	0.000617	0.000765	CcSEcCtD
Flecainide—Dermatitis—Etoposide—testicular cancer	0.000616	0.000764	CcSEcCtD
Flecainide—Headache—Etoposide—testicular cancer	0.000613	0.00076	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—testicular cancer	0.000613	0.00076	CcSEcCtD
Flecainide—Myalgia—Methotrexate—testicular cancer	0.000611	0.000758	CcSEcCtD
Flecainide—Chest pain—Methotrexate—testicular cancer	0.000611	0.000758	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—testicular cancer	0.000611	0.000758	CcSEcCtD
Flecainide—Tension—Doxorubicin—testicular cancer	0.00061	0.000756	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—testicular cancer	0.000609	0.000755	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000607	0.000753	CcSEcCtD
Flecainide—Malaise—Epirubicin—testicular cancer	0.000606	0.000751	CcSEcCtD
Flecainide—Discomfort—Methotrexate—testicular cancer	0.000604	0.000749	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—testicular cancer	0.000604	0.000749	CcSEcCtD
Flecainide—Vertigo—Epirubicin—testicular cancer	0.000604	0.000749	CcSEcCtD
Flecainide—Syncope—Epirubicin—testicular cancer	0.000603	0.000747	CcSEcCtD
Flecainide—Leukopenia—Epirubicin—testicular cancer	0.000601	0.000746	CcSEcCtD
Flecainide—Palpitations—Epirubicin—testicular cancer	0.000594	0.000736	CcSEcCtD
Flecainide—Confusional state—Methotrexate—testicular cancer	0.000591	0.000733	CcSEcCtD
Flecainide—Loss of consciousness—Epirubicin—testicular cancer	0.000591	0.000732	CcSEcCtD
Flecainide—Cough—Epirubicin—testicular cancer	0.000586	0.000727	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—testicular cancer	0.000586	0.000727	CcSEcCtD
Flecainide—Convulsion—Epirubicin—testicular cancer	0.000582	0.000722	CcSEcCtD
Flecainide—Nausea—Etoposide—testicular cancer	0.000581	0.000721	CcSEcCtD
Flecainide—Hypertension—Epirubicin—testicular cancer	0.00058	0.000719	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—testicular cancer	0.000577	0.000715	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—testicular cancer	0.000575	0.000713	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—testicular cancer	0.000574	0.000711	CcSEcCtD
Flecainide—Chest pain—Epirubicin—testicular cancer	0.000572	0.000709	CcSEcCtD
Flecainide—Arthralgia—Epirubicin—testicular cancer	0.000572	0.000709	CcSEcCtD
Flecainide—Myalgia—Epirubicin—testicular cancer	0.000572	0.000709	CcSEcCtD
Flecainide—Anxiety—Epirubicin—testicular cancer	0.00057	0.000707	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—testicular cancer	0.000569	0.000706	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000568	0.000704	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—testicular cancer	0.000566	0.000702	CcSEcCtD
Flecainide—Discomfort—Epirubicin—testicular cancer	0.000565	0.000701	CcSEcCtD
Flecainide—Malaise—Doxorubicin—testicular cancer	0.000561	0.000695	CcSEcCtD
Flecainide—Dry mouth—Epirubicin—testicular cancer	0.000559	0.000694	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—testicular cancer	0.000559	0.000693	CcSEcCtD
Flecainide—Anorexia—Methotrexate—testicular cancer	0.000559	0.000693	CcSEcCtD
Flecainide—Syncope—Doxorubicin—testicular cancer	0.000558	0.000691	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—testicular cancer	0.000557	0.00069	CcSEcCtD
Flecainide—Confusional state—Epirubicin—testicular cancer	0.000553	0.000686	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—testicular cancer	0.000549	0.000681	CcSEcCtD
Flecainide—Oedema—Epirubicin—testicular cancer	0.000548	0.00068	CcSEcCtD
Flecainide—Hypotension—Methotrexate—testicular cancer	0.000548	0.000679	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—testicular cancer	0.000546	0.000678	CcSEcCtD
Flecainide—Cough—Doxorubicin—testicular cancer	0.000543	0.000673	CcSEcCtD
Flecainide—Shock—Epirubicin—testicular cancer	0.00054	0.000669	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—testicular cancer	0.000539	0.000668	CcSEcCtD
Flecainide—Nervous system disorder—Epirubicin—testicular cancer	0.000538	0.000667	CcSEcCtD
Flecainide—Thrombocytopenia—Epirubicin—testicular cancer	0.000537	0.000666	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—testicular cancer	0.000537	0.000666	CcSEcCtD
Flecainide—Tachycardia—Epirubicin—testicular cancer	0.000535	0.000664	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000534	0.000662	CcSEcCtD
Flecainide—Skin disorder—Epirubicin—testicular cancer	0.000533	0.00066	CcSEcCtD
Flecainide—Hyperhidrosis—Epirubicin—testicular cancer	0.00053	0.000657	CcSEcCtD
Flecainide—Insomnia—Methotrexate—testicular cancer	0.00053	0.000657	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—testicular cancer	0.000529	0.000656	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—testicular cancer	0.000529	0.000656	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—testicular cancer	0.000529	0.000656	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—testicular cancer	0.000527	0.000654	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—testicular cancer	0.000526	0.000652	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000526	0.000652	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—testicular cancer	0.000523	0.000648	CcSEcCtD
Flecainide—Anorexia—Epirubicin—testicular cancer	0.000523	0.000648	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—testicular cancer	0.000522	0.000648	CcSEcCtD
Flecainide—Somnolence—Methotrexate—testicular cancer	0.000521	0.000646	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—testicular cancer	0.000518	0.000642	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—testicular cancer	0.000516	0.00064	CcSEcCtD
Flecainide—Hypotension—Epirubicin—testicular cancer	0.000512	0.000635	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—testicular cancer	0.000512	0.000634	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—testicular cancer	0.000509	0.000632	CcSEcCtD
Flecainide—Oedema—Doxorubicin—testicular cancer	0.000507	0.000629	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000506	0.000627	CcSEcCtD
Flecainide—Fatigue—Methotrexate—testicular cancer	0.000505	0.000626	CcSEcCtD
Flecainide—Pain—Methotrexate—testicular cancer	0.000501	0.000621	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.0005	0.000619	CcSEcCtD
Flecainide—Shock—Doxorubicin—testicular cancer	0.000499	0.000619	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—testicular cancer	0.000498	0.000617	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000497	0.000616	CcSEcCtD
Flecainide—Insomnia—Epirubicin—testicular cancer	0.000496	0.000615	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—testicular cancer	0.000495	0.000614	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—testicular cancer	0.000493	0.000611	CcSEcCtD
Flecainide—Paraesthesia—Epirubicin—testicular cancer	0.000492	0.000611	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000491	0.000608	CcSEcCtD
Flecainide—Dyspnoea—Epirubicin—testicular cancer	0.000489	0.000606	CcSEcCtD
Flecainide—Somnolence—Epirubicin—testicular cancer	0.000488	0.000604	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—testicular cancer	0.000484	0.0006	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—testicular cancer	0.000483	0.000599	CcSEcCtD
Flecainide—Dyspepsia—Epirubicin—testicular cancer	0.000483	0.000599	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000479	0.000594	CcSEcCtD
Flecainide—Decreased appetite—Epirubicin—testicular cancer	0.000477	0.000591	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—testicular cancer	0.000474	0.000588	CcSEcCtD
Flecainide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000473	0.000587	CcSEcCtD
Flecainide—Fatigue—Epirubicin—testicular cancer	0.000473	0.000586	CcSEcCtD
Flecainide—Constipation—Epirubicin—testicular cancer	0.000469	0.000581	CcSEcCtD
Flecainide—Pain—Epirubicin—testicular cancer	0.000469	0.000581	CcSEcCtD
Flecainide—Urticaria—Methotrexate—testicular cancer	0.000466	0.000577	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—testicular cancer	0.000463	0.000574	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—testicular cancer	0.000463	0.000574	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000462	0.000573	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—testicular cancer	0.000459	0.000569	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—testicular cancer	0.000456	0.000565	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—testicular cancer	0.000452	0.000561	CcSEcCtD
Flecainide—Feeling abnormal—Epirubicin—testicular cancer	0.000452	0.00056	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—testicular cancer	0.000451	0.000559	CcSEcCtD
Flecainide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000448	0.000556	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—testicular cancer	0.000447	0.000554	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—testicular cancer	0.000441	0.000547	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000438	0.000543	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—testicular cancer	0.000437	0.000542	CcSEcCtD
Flecainide—Urticaria—Epirubicin—testicular cancer	0.000436	0.00054	CcSEcCtD
Flecainide—Constipation—Doxorubicin—testicular cancer	0.000434	0.000538	CcSEcCtD
Flecainide—Pain—Doxorubicin—testicular cancer	0.000434	0.000538	CcSEcCtD
Flecainide—Body temperature increased—Epirubicin—testicular cancer	0.000434	0.000538	CcSEcCtD
Flecainide—Abdominal pain—Epirubicin—testicular cancer	0.000434	0.000538	CcSEcCtD
Flecainide—Asthenia—Methotrexate—testicular cancer	0.00042	0.000521	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—testicular cancer	0.000418	0.000518	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000415	0.000514	CcSEcCtD
Flecainide—Pruritus—Methotrexate—testicular cancer	0.000415	0.000514	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—testicular cancer	0.000403	0.0005	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—testicular cancer	0.000401	0.000497	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—testicular cancer	0.000401	0.000497	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—testicular cancer	0.000401	0.000497	CcSEcCtD
Flecainide—Asthenia—Epirubicin—testicular cancer	0.000393	0.000488	CcSEcCtD
Flecainide—Pruritus—Epirubicin—testicular cancer	0.000388	0.000481	CcSEcCtD
Flecainide—Dizziness—Methotrexate—testicular cancer	0.000388	0.00048	CcSEcCtD
Flecainide—Diarrhoea—Epirubicin—testicular cancer	0.000375	0.000465	CcSEcCtD
Flecainide—Vomiting—Methotrexate—testicular cancer	0.000373	0.000462	CcSEcCtD
Flecainide—Rash—Methotrexate—testicular cancer	0.000369	0.000458	CcSEcCtD
Flecainide—Dermatitis—Methotrexate—testicular cancer	0.000369	0.000458	CcSEcCtD
Flecainide—Headache—Methotrexate—testicular cancer	0.000367	0.000455	CcSEcCtD
Flecainide—Asthenia—Doxorubicin—testicular cancer	0.000364	0.000451	CcSEcCtD
Flecainide—Dizziness—Epirubicin—testicular cancer	0.000363	0.00045	CcSEcCtD
Flecainide—Pruritus—Doxorubicin—testicular cancer	0.000359	0.000445	CcSEcCtD
Flecainide—Vomiting—Epirubicin—testicular cancer	0.000349	0.000432	CcSEcCtD
Flecainide—Nausea—Methotrexate—testicular cancer	0.000348	0.000432	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—testicular cancer	0.000347	0.00043	CcSEcCtD
Flecainide—Rash—Epirubicin—testicular cancer	0.000346	0.000429	CcSEcCtD
Flecainide—Dermatitis—Epirubicin—testicular cancer	0.000345	0.000428	CcSEcCtD
Flecainide—Headache—Epirubicin—testicular cancer	0.000344	0.000426	CcSEcCtD
Flecainide—Dizziness—Doxorubicin—testicular cancer	0.000336	0.000416	CcSEcCtD
Flecainide—Nausea—Epirubicin—testicular cancer	0.000326	0.000404	CcSEcCtD
Flecainide—Vomiting—Doxorubicin—testicular cancer	0.000323	0.0004	CcSEcCtD
Flecainide—Rash—Doxorubicin—testicular cancer	0.00032	0.000397	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—testicular cancer	0.00032	0.000396	CcSEcCtD
Flecainide—Headache—Doxorubicin—testicular cancer	0.000318	0.000394	CcSEcCtD
Flecainide—Nausea—Doxorubicin—testicular cancer	0.000301	0.000374	CcSEcCtD
